Concentration of High-Cost Head and Neck Cancer Surgical Patients

被引:0
作者
Garcia, Jordan [1 ]
Yesantharao, Lekha [1 ]
Frick, Kevin D. [2 ,3 ]
Fakhry, Carole [1 ]
Koch, Wayne [1 ]
Mydlarz, Wojtech [1 ]
Eisele, David W. [1 ]
Gourin, Christine G. [1 ,4 ]
机构
[1] Johns Hopkins Med Inst, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA
[2] Johns Hopkins Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD USA
[3] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA
[4] Johns Hopkins Med Inst, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA
关键词
cost; high-cost; hospital concentration; hospital concentration head and neck cancer; larynx cancer; Nationwide Inpatient Sample; oral cancer; oropharyngeal cancer; surgery; SURGERY;
D O I
10.1002/lary.31618
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective Health care costs are disproportionately concentrated among a small number of patients. We sought to identify variables associated with high-cost patients and high hospital concentration of high-cost patients and to examine associations with short-term outcomes in head and neck cancer (HNCA) surgery. Study Design The Nationwide Inpatient Sample was used to identify 170,577 patients who underwent HNCA surgery in 2001-2011. High-cost patients were defined as patients whose costs of care were in the top decile, and high-concentration hospitals were defined as those whose percentage of high-cost patients was in the top decile. Methods Multivariable regression was used to evaluate associations between cost and patient and hospital variables, postoperative complications, and in-hospital mortality. Results Costs associated with high-cost patients were 4.47-fold greater than the remaining 90% of patients. High-concentration hospitals treated 36% of all high-cost patients. High-cost patients were more likely to be non-white (OR = 2.08 [1.45-2.97]), have oral cavity cancer (OR = 1.21 [1.05-1.39]), advanced comorbidity (OR = 1.53 [1.31-1.77]), Medicaid (OR = 1.93 [1.62-2.31]) or self-pay payor status (OR = 1.72 [1.38-2.14]), income>50th percentile (OR = 1.25 [1.05-1.51]), undergo major procedures (OR = 3.52 [3.07-4.05]) and have non-routine discharge (OR = 7.50 [6.01-9.35]). High-concentration hospitals were more likely to be teaching hospitals (OR = 3.14 [1.64-6.05]) and less likely to be urban (OR = 0.20 [0.04-0.93]). After controlling for all other variables, high-cost patients were associated with an increased odds of mortality (OR = 8.00 [5.89-10.85]) and postoperative complications (OR = 5.88 [5.18-6.68]). High-concentration hospitals were associated with an increased odds of postoperative complications (OR = 1.31 [1.08-1.61]) but were not associated with increased mortality (OR = 0.98 [0.67-1.44]). Conclusions High-cost HNCA surgical patients are associated with increased postoperative morbidity and mortality, and are disproportionately concentrated at teaching hospitals.
引用
收藏
页码:4971 / 4978
页数:8
相关论文
共 50 条
  • [41] Surgical margins in head and neck cancer: Intra- and postoperative considerations
    Robbins, K. Thomas
    Triantafyllou, Asterios
    Suarez, Carlos
    Lopez, Fernando
    Hunt, Jennifer L.
    Strojan, PrimoI
    Williams, Michelle D.
    Braakhuis, Boudewijn J. M.
    de Bree, Remco
    Hinni, Michael L.
    Kowalski, Luiz P.
    Rinaldo, Alessandra
    Rodrigo, Juan P.
    Vander Poorten, Vincent
    Nixon, Lain J.
    Takes, Robert P.
    Silver, Carl E.
    Ferlito, Alfio
    AURIS NASUS LARYNX, 2019, 46 (01) : 10 - 17
  • [42] The Surgical Palliation of Advanced Head and Neck Cancer using Photodynamic Therapy
    Jerjes, W.
    Upile, T.
    Akram, S.
    Hopper, C.
    CLINICAL ONCOLOGY, 2010, 22 (09) : 785 - 791
  • [43] Distant metastasis from head and neck cancer: role of surgical treatment
    Vartanian, Jose Guilherme
    Gross, Jefferson Luis
    Kowalski, Luiz Paulo
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2022, 30 (02) : 114 - 118
  • [44] Mental health comorbidities and cost/utilization outcomes in head and neck cancer patients
    Jeffery, Diana D.
    Ambrosio, Lcdr Art
    Hopkins, Laura
    Burke, Harry B.
    JOURNAL OF PSYCHOSOCIAL ONCOLOGY, 2019, 37 (03) : 301 - 318
  • [45] Predicting High-risk and High-cost Patients for Proactive Intervention
    Gao, Jian
    Moran, Eileen
    Higgins, Donald S., Jr.
    Mecher, Carter
    MEDICAL CARE, 2022, 60 (08) : 610 - 615
  • [46] A specific approach for elderly patients with head and neck cancer
    Ortholan, Cecile
    Benezery, Karen
    Dassonville, Olivier
    Poissonnet, Gilles
    Bozec, Alexandre
    Guiochet, Nicole
    Belkacemi, Yazid
    ANTI-CANCER DRUGS, 2011, 22 (07) : 647 - 655
  • [47] Multidisciplinary Team Planning for Patients with Head and Neck Cancer
    Shellenberger, Thomas D.
    Weber, Randal S.
    ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA, 2018, 30 (04) : 435 - +
  • [48] Pain in head and neck cancer patients: the role of gender
    Bianchini, Chiara
    Corazzi, Virginia
    Malago, Mariasole
    Bellini, Tiziana
    Stomeo, Francesco
    Ciorba, Andrea
    Pelucchi, Stefano
    JOURNAL OF BUON, 2019, 24 (06): : 2220 - 2226
  • [49] Postsurgery enteral nutrition in head and neck cancer patients
    de Luis, DA
    Aller, R
    Izaola, O
    Cuellar, L
    Terroba, MC
    EUROPEAN JOURNAL OF CLINICAL NUTRITION, 2002, 56 (11) : 1126 - 1129
  • [50] Prevalence of Secondary Lymphedema in Patients With Head and Neck Cancer
    Deng, Jie
    Ridner, Sheila H.
    Dietrich, Mary S.
    Wells, Nancy
    Wallston, Kenneth A.
    Sinard, Robert J.
    Cmelak, Anthony J.
    Murphy, Barbara A.
    JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2012, 43 (02) : 244 - 252